Moderna vaccine progress a 'positive development' according to former FDA commissioner, but 'there's a lot of work ahead'
Early data on a coronavirus vaccine candidate is encouraging, but there's still "a lot of work" to be done, the former commissioner of the FDA says.
Moderna on Monday announced some "positive" interim data on its potential COVID-19 vaccine, saying that eight patients in a phase one trial developed antibodies at levels similar to those who recovered from the coronavirus. The stock market surged in reaction to the hope that a vaccine could be on the horizon.
Scott Gottlieb, former Food and Drug Administration commissioner, in an interview on CNBC Tuesday agreed this was a "positive development," since it suggests the vaccine "can produce an immune response." He noted, though, that since Moderna only tested the first eight patients of 45 for neutralizing antibodies, "we need to know the data on the other patients, and whether in fact those are neutralizing antibodies, the kinds of antibodies that target the virus and destroy the virus."
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"They need to figure out what the right dose is for this vaccine, so they're going to need to do a lot of phase two work before they can get into a phase three trial to determine the optimal dose," Gottlieb said. "We also have to make sure that these vaccines are producing neutralizing antibodies."
Based on early data, it now seems "reasonable" to assume we'll get a vaccine against COVID-19 "at some point," Gottlieb concluded. But when? Though President Trump has touted a potential end-of-year timeline, Gottlieb, who previously said a widely-available vaccine is likely a "2021 event," isn't sure about this incredibly tight schedule.
"The timing is questionable," he said, "whether or not we can have it before the end of the year, or whether or not we'll have to wait until 2021 to have a product we can use more generally." Brendan Morrow
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Ukraine using covert US long-range missiles
Speed Read The weapons are part of a $1 billion Ukraine aid package
By Justin Klawans, The Week US Published
-
Arizona grand jury indicts 18 in Trump fake elector plot
Speed Read The state charged Mark Meadows, Rudy Giuliani and other Trump allies in 2020 election interference case
By Peter Weber, The Week US Published
-
Antony Gormley's Time Horizon – a 'judgmental army' of 100 cast-iron men
The Week Recommends Sculptures are 'everymen questioning the privilege of their surroundings' at the Norfolk stately home
By Adrienne Wyper, The Week UK Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published